LAMIVUDINE AND ZIDOVUDINE

Lamivudine And Zidovudine Adverse Events Reported to the FDA Over Time

How are Lamivudine And Zidovudine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lamivudine And Zidovudine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lamivudine And Zidovudine is flagged as the suspect drug causing the adverse event.

Most Common Lamivudine And Zidovudine Adverse Events Reported to the FDA

What are the most common Lamivudine And Zidovudine adverse events reported to the FDA?

Drug Exposure During Pregnancy	324 (8.54%)
Premature Baby	93 (2.45%)
Stillbirth	69 (1.82%)
Abortion Spontaneous	63 (1.66%)
Anaemia	56 (1.48%)
Congenital Anomaly	56 (1.48%)
Abdominal Distension	41 (1.08%)
Cardiac Murmur	41 (1.08%)
Maternal Drugs Affecting Foetus	40 (1.05%)
Ventricular Septal Defect	40 (1.05%)
Cryptorchism	37 (.98%)
	Show More
Polydactyly	35 (.92%)
Abdominal Hernia	33 (.87%)
Pregnancy	32 (.84%)
Small For Dates Baby	30 (.79%)
Pancytopenia	29 (.76%)
Abortion Induced	27 (.71%)
Pyrexia	26 (.69%)
Neutropenia	25 (.66%)
Trisomy 21	24 (.63%)
Sepsis	22 (.58%)
Intra-uterine Death	21 (.55%)
Hydrocephalus	19 (.5%)
Premature Labour	18 (.47%)
Vomiting	18 (.47%)
Caesarean Section	17 (.45%)
Alanine Aminotransferase Increased	16 (.42%)
Aspartate Aminotransferase Increase...	16 (.42%)
Confusional State	16 (.42%)
Diarrhoea	16 (.42%)
Dyspnoea	16 (.42%)
Oesophageal Atresia	16 (.42%)
Rash	16 (.42%)
Respiratory Distress	16 (.42%)
Thrombocytopenia	16 (.42%)
Nausea	15 (.4%)
Coma	14 (.37%)
Convulsion	14 (.37%)
Lactic Acidosis	14 (.37%)
Pain	14 (.37%)
Polyhydramnios	14 (.37%)
Renal Failure	14 (.37%)
Haemoglobin Decreased	13 (.34%)
Malaise	13 (.34%)
Premature Rupture Of Membranes	13 (.34%)
Cardiac Malposition	12 (.32%)
Foetal Growth Retardation	12 (.32%)
Hyperlactacidaemia	12 (.32%)
Immune Reconstitution Syndrome	12 (.32%)
Neonatal Respiratory Distress Syndr...	12 (.32%)
Pneumothorax	12 (.32%)
Spine Malformation	12 (.32%)
Abdominal Pain	11 (.29%)
Congenital Choroid Plexus Cyst	11 (.29%)
Drug Interaction	11 (.29%)
Dysmorphism	11 (.29%)
Hypoglycaemia	11 (.29%)
Jaundice	11 (.29%)
Leukopenia	11 (.29%)
Myocardial Infarction	11 (.29%)
Neuropathy Peripheral	11 (.29%)
Platelet Count Decreased	11 (.29%)
Alpha 1 Foetoprotein Abnormal	10 (.26%)
Ascites	10 (.26%)
Atrial Septal Defect	10 (.26%)
Blood Lactate Dehydrogenase Increas...	10 (.26%)
Cleft Lip And Palate	10 (.26%)
Hemivertebra	10 (.26%)
Overdose	10 (.26%)
Alpha 1 Foetoprotein Increased	9 (.24%)
Bone Marrow Failure	9 (.24%)
Bradycardia	9 (.24%)
Encephalopathy	9 (.24%)
Foetal Distress Syndrome	9 (.24%)
Gastritis	9 (.24%)
Gastrointestinal Disorder	9 (.24%)
General Physical Health Deteriorati...	9 (.24%)
Hydrocele	9 (.24%)
Hypersensitivity	9 (.24%)
Liver Function Test Abnormal	9 (.24%)
Neonatal Disorder	9 (.24%)
Oedema Peripheral	9 (.24%)
Placental Disorder	9 (.24%)
Pruritus	9 (.24%)
Renal Failure Acute	9 (.24%)
Respiratory Disorder	9 (.24%)
Blood Creatine Phosphokinase Increa...	8 (.21%)
C-reactive Protein Increased	8 (.21%)
Congenital Foot Malformation	8 (.21%)
Cytolytic Hepatitis	8 (.21%)
Death	8 (.21%)
Double Outlet Right Ventricle	8 (.21%)
Headache	8 (.21%)
Hepatic Displacement	8 (.21%)
Hepatic Function Abnormal	8 (.21%)
Patent Ductus Arteriosus	8 (.21%)
Pneumonia	8 (.21%)
Talipes	8 (.21%)
Trisomy 18	8 (.21%)
Blood Alkaline Phosphatase Increase...	7 (.18%)
Blood Creatinine Increased	7 (.18%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Lamivudine And Zidovudine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lamivudine And Zidovudine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lamivudine And Zidovudine

What are the most common Lamivudine And Zidovudine adverse events reported to the FDA?

Chemical Injury And Poisoning	371 (9.78%)
Abortions And Stillbirth	159 (4.19%)
Neonatal And Perinatal Conditions	143 (3.77%)
Musculoskeletal And Connective Tiss...	126 (3.32%)
Anemias Nonhemolytic And Marrow Dep...	113 (2.98%)
Hepatic And Hepatobiliary	111 (2.93%)
Cardiac And Vascular Disorders Cong...	108 (2.85%)
Gastrointestinal Signs	103 (2.72%)
Infections - Pathogen Unspecified	89 (2.35%)
Respiratory	81 (2.14%)
Epidermal And Dermal Conditions	77 (2.03%)
	Show More
Hepatobiliary	68 (1.79%)
Congenital And Hereditary	67 (1.77%)
Gastrointestinal Tract Disorders Co...	62 (1.63%)
Cardiac And Vascular Investigations	58 (1.53%)
Hematology Investigations	55 (1.45%)
Reproductive Tract And Breast Disor...	53 (1.4%)
Neurological	52 (1.37%)
Obstetric And Gynecological Therape...	44 (1.16%)
Placental, Amniotic And Cavity Diso...	43 (1.13%)
Renal Disorders	42 (1.11%)
Pregnancy, Labour, Delivery And Pos...	40 (1.05%)
White Blood Cell	40 (1.05%)
Abdominal Hernias And Other Abdomin...	39 (1.03%)
Chromosomal Abnormalities And Abnor...	38 (1%)
Neurological Disorders Congenital	36 (.95%)
Viral Infectious	35 (.92%)
Fetal Complications	34 (.9%)
Body Temperature Conditions	33 (.87%)
Maternal Complications Of Labour An...	33 (.87%)
Acid-base	30 (.79%)
Cardiac Arrhythmias	30 (.79%)
Glucose Metabolism Disorders	28 (.74%)
Protein And Chemistry Analyses	28 (.74%)
Enzyme	27 (.71%)
Neonatal Respiratory	27 (.71%)
Bacterial Infectious	26 (.69%)
Therapeutic And Nontherapeutic Effe...	25 (.66%)
Pleural	24 (.63%)
Medication Errors	23 (.61%)
Respiratory Disorders Congenital	23 (.61%)
Gastrointestinal Inflammatory Condi...	22 (.58%)
Increased Intracranial Pressure And...	22 (.58%)
Myocardial	21 (.55%)
Renal And Urinary Tract Disorders C...	20 (.53%)
Seizures	20 (.53%)
Embolism And Thrombosis	18 (.47%)
Platelet	18 (.47%)
Electrolyte And Fluid Balance Condi...	17 (.45%)
Gastrointestinal Motility And Defec...	17 (.45%)
Renal And Urinary Tract Investigati...	17 (.45%)
Urinary Tract Signs	17 (.45%)
Deliria	16 (.42%)
Musculoskeletal And Connective Tiss...	16 (.42%)
Ocular Infections, Irritations And ...	16 (.42%)
Physical Examination Topics	16 (.42%)
Coronary Artery	15 (.4%)
Bone, Calcium, Magnesium And Phosph...	14 (.37%)
Gastrointestinal Conditions	14 (.37%)
Immunodeficiency Syndromes	14 (.37%)
Maternal Complications Of Pregnancy	14 (.37%)
Muscle	14 (.37%)
Allergic Conditions	13 (.34%)
Encephalopathies	13 (.34%)
Peripheral Neuropathies	13 (.34%)
Fetal And Neonatal	12 (.32%)
Peritoneal And Retroperitoneal Cond...	12 (.32%)
Upper Respiratory Tract Disorders	12 (.32%)
Decreased And Nonspecific Blood Pre...	11 (.29%)
Vision	11 (.29%)
Disturbances In Thinking	10 (.26%)
Fatal Outcomes	10 (.26%)
Injuries	10 (.26%)
Lower Respiratory Tract Disorders	10 (.26%)
Metabolic And Nutritional Disorders...	10 (.26%)
Microbiology And Serology	10 (.26%)
Central Nervous System Vascular	9 (.24%)
Eye	9 (.24%)
Headaches	9 (.24%)
Lipid Metabolism	9 (.24%)
Pulmonary Vascular	9 (.24%)
Skin And Subcutaneous Tissue Disord...	9 (.24%)
Appetite And General Nutritional	8 (.21%)
Cardiac Disorder Signs	8 (.21%)
Hearing	8 (.21%)
Lipid Analyses	8 (.21%)
Metabolic, Nutritional And Blood Ga...	8 (.21%)
Neurological, Special Senses And Ps...	8 (.21%)
Protozoal Infectious	8 (.21%)
Spleen, Lymphatic And Reticulendoth...	8 (.21%)
Urolithiases	8 (.21%)
Blood And Lymphatic System Disorder...	7 (.18%)
Coagulopathies And Bleeding Diathes...	7 (.18%)
Eye Disorders Congenital	7 (.18%)
Fungal Infectious	7 (.18%)
Lifestyle Issues	7 (.18%)
Metabolism	7 (.18%)
Movement Disorders	7 (.18%)
Skin Vascular Abnormalities	7 (.18%)
Suicidal And Self-injurious Behavio...	7 (.18%)
Thyroid Gland	7 (.18%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lamivudine And Zidovudine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lamivudine And Zidovudine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.